Morich Frank is a director of Cue Biopharma, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Perspective Therapeutics, Inc.
24 Jun 24
4
Cue Biopharma, Inc.
4 Jan 24
4
Perspective Therapeutics, Inc.
14 Dec 23
4
Perspective Therapeutics, Inc.
23 Feb 23
3
Isoray, Inc.
13 Feb 23
4
Cue Biopharma, Inc.
5 Jan 23
4
Cue Biopharma, Inc.
31 May 22
4
Cue Biopharma, Inc.
5 Jan 22
4
Cue Biopharma, Inc.
6 Jan 21
4
Cue Biopharma, Inc.
12 May 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jun 24 | CATX Perspective Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 10.65 | 23,000 | 244.95 k | 23,000 |
2 Jan 24 | CUE Cue Biopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 2.78 | 24,400 | 67.83 k | 24,400 |
12 Dec 23 | CATX Perspective Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 0.24 | 230,000 | 55.20 k | 2,037,471 |